Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02212951 · ClinicalTrials.gov registry record · Phase 1
Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
A Phase 1 study, sponsored by Biodel.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02212951 is a Phase 1 study that has completed, run by Biodel. The registered enrollment target is 12 participants.
The verdict
NCT02212951, a Phase 1 study, has completed, sponsored by Biodel.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The study is to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500.
Interventions
- DRUG Humulin R U-500
- DRUG BIOD-531
- DRUG Humalog Mix 75/25
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02212951
The ClinicalTrials.gov registry entry for NCT02212951 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biodel, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Humulin R U-500 is the first listed.
NCT02212951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02212951 about?
NCT02212951 is a clinical study titled "Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500". The study is to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500.
What is the current status of trial NCT02212951?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-05.
What interventions are being tested in trial NCT02212951?
The interventions under investigation include: Humulin R U-500 (DRUG), BIOD-531 (DRUG), Humalog Mix 75/25 (DRUG).
Who is sponsoring clinical trial NCT02212951?
This trial is sponsored by Biodel, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.